Literature DB >> 17008370

Ca2+ sensitivity of regulated cardiac thin filament sliding does not depend on myosin isoform.

Brenda Schoffstall1, Nicolas M Brunet, Shanedah Williams, Victor F Miller, Alyson T Barnes, Fang Wang, Lisa A Compton, Lori A McFadden, Dianne W Taylor, Margaret Seavy, Rani Dhanarajan, P Bryant Chase.   

Abstract

Myosin heavy chain (MHC) isoforms in vertebrate striated muscles are distinguished functionally by differences in chemomechanical kinetics. These kinetic differences may influence the cross-bridge-dependent co-operativity of thin filament Ca(2+) activation. To determine whether Ca(2+) sensitivity of unloaded thin filament sliding depends upon MHC isoform kinetics, we performed in vitro motility assays with rabbit skeletal heavy meromyosin (rsHMM) or porcine cardiac myosin (pcMyosin). Regulated thin filaments were reconstituted with recombinant human cardiac troponin (rhcTn) and alpha-tropomyosin (rhcTm) expressed in Escherichia coli. All three subunits of rhcTn were coexpressed as a functional complex using a novel construct with a glutathione S-transferase (GST) affinity tag at the N-terminus of human cardiac troponin T (hcTnT) and an intervening tobacco etch virus (TEV) protease site that allows purification of rhcTn without denaturation, and removal of the GST tag without proteolysis of rhcTn subunits. Use of this highly purified rhcTn in our motility studies resulted in a clear definition of the regulated motility profile for both fast and slow MHC isoforms. Maximum sliding speed (pCa 5) of regulated thin filaments was roughly fivefold faster with rsHMM compared with pcMyosin, although speed was increased by 1.6- to 1.9-fold for regulated over unregulated actin with both MHC isoforms. The Ca(2+) sensitivity of regulated thin filament sliding speed was unaffected by MHC isoform. Our motility results suggest that the cellular changes in isoform expression that result in regulation of myosin kinetics can occur independently of changes that influence thin filament Ca(2+) sensitivity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17008370      PMCID: PMC1890378          DOI: 10.1113/jphysiol.2006.120105

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  39 in total

1.  Effects of myosin heavy chain isoform switching on Ca2+-activated tension development in single adult cardiac myocytes.

Authors:  J M Metzger; P A Wahr; D E Michele; F Albayya; M V Westfall
Journal:  Circ Res       Date:  1999-06-11       Impact factor: 17.367

2.  Kinetic differences at the single molecule level account for the functional diversity of rabbit cardiac myosin isoforms.

Authors:  K A Palmiter; M J Tyska; D E Dupuis; N R Alpert; D M Warshaw
Journal:  J Physiol       Date:  1999-09-15       Impact factor: 5.182

3.  Comparison of unitary displacements and forces between 2 cardiac myosin isoforms by the optical trap technique: molecular basis for cardiac adaptation.

Authors:  S Sugiura; N Kobayakawa; H Fujita; H Yamashita; S Momomura; S Chaen; M Omata; H Sugi
Journal:  Circ Res       Date:  1998-06-01       Impact factor: 17.367

4.  Calcium regulation of skeletal muscle thin filament motility in vitro.

Authors:  A M Gordon; M A LaMadrid; Y Chen; Z Luo; P B Chase
Journal:  Biophys J       Date:  1997-03       Impact factor: 4.033

5.  Ca(2+)-regulated structural changes in troponin.

Authors:  Maia V Vinogradova; Deborah B Stone; Galina G Malanina; Christina Karatzaferi; Roger Cooke; Robert A Mendelson; Robert J Fletterick
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-22       Impact factor: 11.205

6.  Myosin heavy chain gene expression in human heart failure.

Authors:  K Nakao; W Minobe; R Roden; M R Bristow; L A Leinwand
Journal:  J Clin Invest       Date:  1997-11-01       Impact factor: 14.808

7.  Cardiac myosin isoforms from different species have unique enzymatic and mechanical properties.

Authors:  Ulf P Malmqvist; Alexander Aronshtam; Susan Lowey
Journal:  Biochemistry       Date:  2004-11-30       Impact factor: 3.162

8.  Impact of beta-myosin heavy chain isoform expression on cross-bridge cycling kinetics.

Authors:  Veronica L M Rundell; Vlasios Manaves; Anne F Martin; Pieter P de Tombe
Journal:  Am J Physiol Heart Circ Physiol       Date:  2004-10-07       Impact factor: 4.733

9.  Effects of rapamycin on cardiac and skeletal muscle contraction and crossbridge cycling.

Authors:  Brenda Schoffstall; Aya Kataoka; Amanda Clark; P Bryant Chase
Journal:  J Pharmacol Exp Ther       Date:  2004-08-11       Impact factor: 4.030

Review 10.  Molecular diversity of myofibrillar proteins: gene regulation and functional significance.

Authors:  S Schiaffino; C Reggiani
Journal:  Physiol Rev       Date:  1996-04       Impact factor: 37.312

View more
  21 in total

1.  Tropomyosin in the groove? Molecular insights into an inherited myopathy.

Authors:  P Bryant Chase
Journal:  J Physiol       Date:  2007-05-24       Impact factor: 5.182

2.  Slowed Dynamics of Thin Filament Regulatory Units Reduces Ca2+-Sensitivity of Cardiac Biomechanical Function.

Authors:  Campion K P Loong; Aya K Takeda; Myriam A Badr; Jordan S Rogers; P Bryant Chase
Journal:  Cell Mol Bioeng       Date:  2013-06-01       Impact factor: 2.321

Review 3.  Nuclear tropomyosin and troponin in striated muscle: new roles in a new locale?

Authors:  P Bryant Chase; Mark P Szczypinski; Elliott P Soto
Journal:  J Muscle Res Cell Motil       Date:  2013-08-02       Impact factor: 2.698

4.  The functional significance of the last 5 residues of the C-terminus of cardiac troponin I.

Authors:  Jennifer E Gilda; Qian Xu; Margaret E Martinez; Susan T Nguyen; P Bryant Chase; Aldrin V Gomes
Journal:  Arch Biochem Biophys       Date:  2016-02-23       Impact factor: 4.013

5.  Site-specific acetyl-mimetic modification of cardiac troponin I modulates myofilament relaxation and calcium sensitivity.

Authors:  Ying H Lin; William Schmidt; Kristofer S Fritz; Mark Y Jeong; Anthony Cammarato; D Brian Foster; Brandon J Biesiadecki; Timothy A McKinsey; Kathleen C Woulfe
Journal:  J Mol Cell Cardiol       Date:  2020-01-22       Impact factor: 5.000

6.  Ca2+-independent positive molecular inotropy for failing rabbit and human cardiac muscle by alpha-myosin motor gene transfer.

Authors:  Todd J Herron; Eric Devaney; Lakshmi Mundada; Erik Arden; Sharlene Day; Guadalupe Guerrero-Serna; Immanuel Turner; Margaret Westfall; Joseph M Metzger
Journal:  FASEB J       Date:  2009-10-02       Impact factor: 5.191

7.  Enhanced active cross-bridges during diastole: molecular pathogenesis of tropomyosin's HCM mutations.

Authors:  Fan Bai; Adam Weis; Aya K Takeda; P Bryant Chase; Masataka Kawai
Journal:  Biophys J       Date:  2011-02-16       Impact factor: 4.033

8.  Several cardiomyopathy causing mutations on tropomyosin either destabilize the active state of actomyosin or alter the binding properties of tropomyosin.

Authors:  Mohit C Mathur; P Bryant Chase; Joseph M Chalovich
Journal:  Biochem Biophys Res Commun       Date:  2011-02-03       Impact factor: 3.575

9.  Removing the regulatory N-terminal domain of cardiac troponin I diminishes incompatibility during bacterial expression.

Authors:  Zhi-Bin Yu; Jiang-Ping Jin
Journal:  Arch Biochem Biophys       Date:  2007-01-31       Impact factor: 4.013

10.  Role of cardiac troponin I carboxy terminal mobile domain and linker sequence in regulating cardiac contraction.

Authors:  Nancy L Meyer; P Bryant Chase
Journal:  Arch Biochem Biophys       Date:  2016-03-10       Impact factor: 4.013

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.